http://www.ncbi.nlm.nih.gov/pubmed/21114772
Asia Pac J Clin Oncol. 2010 Dec;6(4):248-50. doi: 10.1111/j.1743-7563.2010.01362.x.
Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?
Tamura K, Fujiwara Y.
Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
No comments:
Post a Comment